首页> 外文OA文献 >Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial

【2h】

Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial

机译：依维莫司联合依西美坦治疗与安慰剂联合依西美坦治疗的晚期乳腺癌患者的健康相关生活质量在3期随机，对照，BOLERO-2试验中

页面导航

摘要
著录项
相似文献
相关主题

摘要

The randomized, controlled BOLERO-2 (Breast Cancer Trials of Oral Everolimus) trial demonstrated significantly improved progression-free survival with the use of everolimus plus exemestane (EVE + EXE) versus placebo plus exemestane (PBO + EXE) in patients with advanced breast cancer who developed disease progression after treatment with nonsteroidal aromatase inhibitors. This analysis investigated the treatment effects on health-related quality of life (HRQOL).

机译：随机对照BOLERO-2（口服Everolimus乳腺癌试验）试验显示，与安慰剂加exemestane（PBO + EXE）相比，使用Everolimus加exemestane（EVE + EXE）显着改善了晚期乳腺癌患者的无进展生存期用非甾体芳香酶抑制剂治疗后疾病发展的人。该分析调查了治疗对健康相关生活质量（HRQOL）的影响。

著录项

作者
Burris Howard A; Lebrun Fabienne; Rugo Hope S; Beck J Thaddeus; Piccart Martine; Neven Patrick; Baselga Jose; Petrakova Katarina; Hortobagyi Gabriel N; Komorowski Anna; Chouinard Edmond; Young Robyn; Gnant Michael; Pritchard Kathleen I; Bennett Lee; Ricci Jean-Francois; Bauly Hounayda; Taran Tetiana; Sahmoud Tarek; Noguchi Shinzaburo;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial (vol 119, pg 1908, 2013) [J] . Burris H. A., Lebrun F., Rugo J. S. Cancer: A Journal of the American Cancer Society . 2019,第8期

机译：患有Everolimus Plus Exemestane的健康相关的乳腺癌患者的生活质量与Applbo加上的Applbo Plus Exemestane在第3阶段，随机，控制，Bolero-2试验（Vol 119，PG 1908,2013）
2. Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial [J] . BurrisIIIH.A., LebrunF., RugoH.S., Cancer: A Journal of the American Cancer Society . 2013,第10期

机译：依维莫司联合依西美坦治疗与安慰剂联合依西美坦治疗的晚期乳腺癌患者的健康相关生活质量在3期随机，对照，BOLERO-2试验中
3. Health-related quality of life and disease symptoms in postmenopausal women with hr+, her2- advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy [J] . CamponeM., BeckJ.T., GnantM., Current medical research and opinion . 2013,第11期

机译：依维莫司联合依西美坦与依西美坦单药治疗的hr +，her2-晚期乳腺癌绝经后妇女的健康相关生活质量和疾病症状
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Final results from IMPROVE: a randomized controlled open-label two-arm cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive HER2-negative breast cancer [O] . Thomas Decker, Ulrike Söling, Antje Hahn, 2020

机译：IMPROVE的最终结果：一项随机对照开放标签双臂交叉的IV期研究确定患者对依维莫司联合依西美坦或卡培他滨与贝伐单抗联合贝伐单抗联合治疗晚期HR阳性HER2阴性的偏好乳腺癌
7. Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial [O] . Burris Howard H.A., Lebrun Fabienne, Piccart-Gebhart Martine, 2013

机译：依维莫司联合依西美坦治疗与安慰剂联合依西美坦治疗的晚期乳腺癌患者的健康相关的生活质量，处于随机，对照，BOLERO-2试验第三阶段

Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial

摘要

著录项

相似文献

相关主题

期刊订阅